HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: From Prediction to Practice: Rethinking Chronic Disease Management in Value-Based Care
  • The AI leadership gap threatening value-based care
  • Reengineering ACOs To Make Medicare Competitive
  • RECORDED WEBINAR: Thriving Under TEAM and Building Toward CMS’s 2030 Value-Based Care Goal
  • RECORDED WEBINAR: Reading the Future of Medicare Value-Based Care in CMS Payment Models
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us